Incretin Peptide
Synthetic dual GIP and GLP-1 receptor agonist peptide. Studied in vitro for receptor binding affinity, downstream cAMP signaling, and incretin pathway activity.
Incretin Peptide
Synthetic dual GIP and GLP-1 receptor agonist peptide. Studied in vitro for receptor binding affinity, downstream cAMP signaling, and incretin pathway activity.
This certificate is hosted by the testing laboratory.
It can't be previewed here — open it directly to view or download.
Open certificate ↗Incretin Peptide
Synthetic dual GIP and GLP-1 receptor agonist peptide. Studied in vitro for receptor binding affinity, downstream cAMP signaling, and incretin pathway activity.
10MG, 10MG (Three Vials), 20MG, 20MG (Three Vials), 30MG, 30MG (Three Vials), 60MG, 60MG (Three Vials), 100MG, 100MG (Three Vials), 120MG, 120MG (Three Vials)
Averix Labs uses cookies and similar technologies to operate our website, analyse usage, and support our services. We do not use advertising cookies. You can manage your data sale preferences below.
Required for the website to function — shopping cart, checkout, account login. Cannot be disabled.
Help us understand how visitors use our website so we can improve the experience. No personal data is sold.